Literature DB >> 4200481

Resistance of Pseudomonas aeruginosa to gentamicin.

P Chadwick.   

Abstract

The resistance to gentamicin 4 mug./ml. of 250 Pseudomonas aeruginosa isolates was measured by a proportion method. Twenty-eight (11.2%) of the cultures fell into the most resistant group, in whose populations between 10 and 100% of the organisms were resistant. A relatively high percentage of urinary isolates and a comparatively low percentage of isolates from respiratory sources occurred in this group. Three of the 28 were resistant to carbenicillin 150 mug./ml. and 6 of 18 tested were as resistant to gentamicin 8 mug./ml. as they were to 4 mug./ml. The distribution of Ps. aeruginosa isolates between the different grades of resistance did not change significantly during the 10 months in which the survey was performed.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4200481      PMCID: PMC1946942     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  19 in total

1.  Dose of gentamicin in patients with normal renal function and renal impairment.

Authors:  J C Gingell; P M Waterworth
Journal:  Br Med J       Date:  1968-04-06

2.  Transferable and non-transferable drug resistance in enteric bacteria isolated from urinary specimens in Northern Sweden.

Authors:  S Bergfors; L G Burman; P H Eklöf; K Nordström; A Tärnvik
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

3.  Resistance of Pseudomonas aeruginosa to carbenicillin.

Authors:  S M Bell; D D Smith
Journal:  Lancet       Date:  1969-04-12       Impact factor: 79.321

4.  Sensitivity of Pseudomonas aeruginosa to antibiotics: emergence of strains highly resistant to carbenicillin.

Authors:  E J Lowbury; H A Lilly; A Kidson; G A Ayliffe; R J Jones
Journal:  Lancet       Date:  1969-08-30       Impact factor: 79.321

5.  Intergeneric transfer of a beta-lactamase gene between Ps. aeruginosa and E. coli.

Authors:  R B Sykes; M H Richmond
Journal:  Nature       Date:  1970-06-06       Impact factor: 49.962

6.  Studies on the epidemiology of resistance (R) factors. I. Analysis of Klebsiella isolates in a general hospital. II. A prospective study of R factor transfer in the host.

Authors:  P Gardner; D H Smith
Journal:  Ann Intern Med       Date:  1969-07       Impact factor: 25.391

7.  Antimicrobial activity of the carbenicillin-gentamicin combination against gram-negative bacilli.

Authors:  J Klastersky; G Swings; D Daneau
Journal:  Am J Med Sci       Date:  1970-12       Impact factor: 2.378

8.  Dosage of gentamicin for pseudomonas infections.

Authors:  J H Darrell; P M Waterworth
Journal:  Br Med J       Date:  1967-05-27

9.  Carbenicillin and gentamicin in the treatment of Pseudomonas aeruginosa infection.

Authors:  K Yuce; C E Van Rooyen
Journal:  Can Med Assoc J       Date:  1971-11       Impact factor: 8.262

10.  Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate.

Authors:  W H Traub; E A Raymond
Journal:  Appl Microbiol       Date:  1972-01
View more
  7 in total

1.  Serotypes of Pseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility.

Authors:  N J Legakis; M Aliferopoulou; J Papavassiliou; M Papapetropoulou
Journal:  J Clin Microbiol       Date:  1982-09       Impact factor: 5.948

2.  Surveillance of gentamicin-resistant gram-negative bacilli in a general hospital.

Authors:  C A Kauffman; N C Ramundo; S G Williams; C R Dey; J P Phair; C Watanakunakorn
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

3.  In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.

Authors:  C Watanakunakorn; C A Kauffman
Journal:  Infection       Date:  1978       Impact factor: 3.553

4.  Nosocomial infection with gentamicin-carbenicillin-resistant Pseudomonas aeruginosa.

Authors:  I M Baird; J M Slepack; C A Kauffman; J P Phair
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

5.  Virulence in rats of gentamicin-carbenicillin-resistant Pseudomonas.

Authors:  J M Slepack; T Korfhagen; J C Loper; J S Tan; J P Phair
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

6.  Emergence of gentamicin- and carbenicillin-resistant Pseudomonas aeruginosa in a hospital environment.

Authors:  W Gaman; C Cates; C F Snelling; B Lank; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

7.  Comparison of in vitro antibacterial activities of gentamicin and verdamicin.

Authors:  P K Yu; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.